Loading clinical trials...
Loading clinical trials...
Risk Adapted De-Intensification of Radio-Chemotherapy for Favorable Prognosis Oropharyngeal Squamous Cell Carcinoma Based on HPV Subtype and Plasma Circulating Free HPV DNA Level and Clearance Rate
Conditions
Interventions
Radiation therapy
Cisplatin
Locations
3
United States
University of Florida
Gainesville, Florida, United States
UF Health Proton Therapy Institute
Jacksonville, Florida, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Start Date
May 16, 2022
Primary Completion Date
June 1, 2029
Completion Date
June 1, 2032
Last Updated
April 24, 2026
NCT06532279
NCT05307939
NCT06980038
NCT06868433
NCT02734537
NCT05639972
Lead Sponsor
University of Florida
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions